Breaking News

You are here » Indian-Commodity  :  Equity & Shares  :  Lupin gains on receiving USFDA's approval for generic Dovonex Scalp Solution

29-Dec2017

Lupin gains on receiving USFDA's approval for generic Dovonex Scalp Solution

Lupin is currently trading at Rs. 889.90, up by 9.05 points or 1.03% from its previous closing of Rs. 880.85 on the BSE.

The scrip opened at Rs. 898.00 and has touched a high and low of Rs. 900.00 and Rs. 886.75 respectively. So far 1,53,000 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1572.25 on 06-Feb-2017 and a 52 week low of Rs. 807.00 on 06-Dec-2017.

Last one week high and low of the scrip stood at Rs. 900.00 and Rs. 865.10 respectively. The current market cap of the company is Rs. 40,225.00 crore.

The promoters holding in the company stood at 46.80%, while Institutions and Non-Institutions held 40.05% and 13.14% respectively.

Lupin has received final approval for its Calcipotriene Topical Solution, 0.005% (Scalp Solution) from the United States Food and Drug Administration (USFDA) to market a generic version of Dovonex Scalp Solution, 0.005% of Leo Pharmaceutical Products.

Lupin's Calcipotriene Topical Solution, 0.005% (Scalp Solution) is the AT rated generic equivalent of Leo Pharmaceutical Products' Dovonex Scalp Solution, 0.005%. It is indicated for the topical treatment of chronic, moderately severe psoriasis of the scalp.

Calcipotriene Topical Solution, 0.005% (Scalp Solution) had annual sales of approximately $5.9 million in the US (IMS MAT October 2017).

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.



Related News

View all news

SBI Life shines on reporting 15% rise in Q3 net profit

SBI Life Insurance Company is currently trading at Rs. 635.45, up by 15.65 points or 2.53% from its previous closing of Rs. 619.80 on the BSE.The scrip opened at Rs. 621.00 and has touched a high and low......

Reliance Industries zooms on the bourses

Reliance Industries is currently trading at Rs. 1219.00, up by 36.05 points or 3.05% from its previous closing of Rs. 1182.95 on the BSE.The scrip opened at Rs. 1193.90 and has touched a high and low of......

Infosys surges on the BSE

Infosys is currently trading at Rs. 746.30, up by 15.30 points or 2.09% from its previous closing of Rs. 731.00 on the BSE.The scrip opened at Rs. 733.00 and has touched a high and low of Rs. 750.70 and......

Top News

View all news

Glenmark Pharma recalling 96,240 applicators of its product from US

Glenmark Pharmaceuticals is recalling 96,240 applicators of its product Estradiol vaginal inserts for defective delivery system. The USFDA has termed it as a Class-II recall. The USFDA has classified Class-II......

Infosys hires over 7,600 staff in US

Infosys has hired over 7,600 staff in the US. This hiring is more than three-fourth of its target of recruiting 10,000 American workers. The company is making recruitment from local schools a 'sustained......

SBI to sell 26% stake of SBI payment services

State Bank of India (SBI) is planning to sell 26% stake of its SBI payment services (SPSPL) to Hitachi Payment Services (HPY). After allotment of the shares, SBI shareholding in SPSPL will become 74% from......